In summary, our finding that SumayaVac-1 elicits broad, functional B and T cell responses implicated in controlling a P. falciparum infection at the blood, revitalizes MSP1 as a relevant malaria vaccine candidate. This evidence concerns the gene ATAD1 and malaria.